NeurAxis (NRXS) News Today $2.40 0.00 (0.00%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period NeurAxis files for secondary mixed shelf offeringDecember 13, 2024 | msn.comNeuraxis files $25M mixed securities shelfDecember 13, 2024 | markets.businessinsider.comNeuraxis files to sell 6.57M shares of common stock for holdersDecember 13, 2024 | markets.businessinsider.comNeurAxis, Inc.: NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic ConstipationDecember 10, 2024 | finanznachrichten.deNeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic ConstipationDecember 10, 2024 | markets.businessinsider.comNeurAxis, Inc. (NASDAQ:NRXS) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comNeurAxis, Inc (NRXS) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comNeurAxis Reports Strong Revenue Growth in Q3 2024November 14, 2024 | markets.businessinsider.comNeurAxis, Inc.: NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in RevenuesNovember 13, 2024 | finanznachrichten.deNeuraxis reports Q3 revenue $667k vs $477k last yearNovember 13, 2024 | markets.businessinsider.comNeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in RevenuesNovember 12, 2024 | globenewswire.comNeuraxis receives new FDA 510k clearance for IB-StimNovember 4, 2024 | markets.businessinsider.comNeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable MarketNovember 4, 2024 | markets.businessinsider.comNeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field StimulationOctober 22, 2024 | globenewswire.comThe Zacks Analyst Blog Highlights Costco Wholesale, Alibaba, GE Aerospace, Applied Energetics and NeurAxisSeptember 25, 2024 | finance.yahoo.comNeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024September 19, 2024 | globenewswire.comVBI Vaccines Inc. (VBIVQ)August 29, 2024 | uk.finance.yahoo.comNeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024August 27, 2024 | globenewswire.comNeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024August 13, 2024 | globenewswire.comNeurAxis, Inc. (NASDAQ:NRXS) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | msn.comNeurAxis, Inc.: NeurAxis Reports Second Quarter 2024 Financial ResultsAugust 10, 2024 | finanznachrichten.deNeurAxis Reports Second Quarter 2024 Financial ResultsAugust 9, 2024 | globenewswire.comNeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit DisclosureJune 7, 2024 | globenewswire.comNeurAxis, Inc. (NASDAQ:NRXS) Q1 2024 Earnings Call TranscriptMay 24, 2024 | msn.comNeurAxis, Inc.: NeurAxis Reports First Quarter 2024 Financial ResultsMay 22, 2024 | finanznachrichten.deNeurAxis GAAP EPS of -$0.32, revenue of $0.65MMay 22, 2024 | msn.comNeurAxis Reports First Quarter 2024 Financial ResultsMay 22, 2024 | globenewswire.comNeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 21, 2024 | globenewswire.comNeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in FloridaMay 16, 2024 | finance.yahoo.comNeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024May 15, 2024 | globenewswire.comNeurAxis Announces New Medical Policy Coverage in North DakotaApril 23, 2024 | globenewswire.comNeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call TranscriptApril 12, 2024 | finance.yahoo.comNeurAxis, Inc.: NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 11, 2024 | finanznachrichten.deNeurAxis, Inc. (NRXS) Q4 2023 Earnings Call TranscriptApril 11, 2024 | seekingalpha.comNeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 9, 2024 | globenewswire.comNeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024April 1, 2024 | globenewswire.comNeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center RegistryMarch 27, 2024 | globenewswire.comNeurAxis Announces Highmark BCBS Policy CoverageMarch 11, 2024 | globenewswire.comNeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy CoverageMarch 4, 2024 | globenewswire.comNeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceFebruary 27, 2024 | globenewswire.comNeurAxis, Inc. (NRXS)February 1, 2024 | au.finance.yahoo.comNeurAxis, Inc.: NeurAxis Appoints Timothy Henrichs as Chief Financial OfficerJanuary 31, 2024 | finanznachrichten.deNeurAxis Appoints Timothy Henrichs as Chief Financial OfficerJanuary 31, 2024 | finance.yahoo.comNeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerDecember 20, 2023 | finanznachrichten.deNeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerDecember 20, 2023 | finance.yahoo.comNeurAxis, Inc.: NeurAxis Reports Third Quarter 2023 Financial ResultsNovember 21, 2023 | finanznachrichten.deNeurAxis reports Q3 resultsNovember 21, 2023 | msn.comNeurAxis Reports Third Quarter 2023 Financial ResultsNovember 20, 2023 | finance.yahoo.comNeurAxis Announces CareFirst BCBS Policy CoverageNovember 15, 2023 | finance.yahoo.comNeurAxis secures $3M financing through preferred stock offeringNovember 14, 2023 | msn.com Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW NRXS Media Mentions By Week NRXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXS News Sentiment▼0.000.60▲Average Medical News Sentiment NRXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXS Articles This Week▼00▲NRXS Articles Average Week Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Apyx Medical News Milestone Scientific News Outset Medical News Alpha Pro Tech News Modular Medical News Cytosorbents News Nexalin Technology News Nutriband News iCAD News Lucid Diagnostics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
